Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel
Bratislava Medical Journal · 2024
DOI: 10.4149/bll_2024_115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bratislava Medical Journal, 2024. Verfasst von Maria Novisedlakova und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Fluorouracil, Irinotecan. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Novisedlakova, M., Chovanec, M., Ciernikova, S., & Danihel, L. (2024). Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel. Bratislava Medical Journal. https://doi.org/10.4149/bll_2024_115
Vancouver
Novisedlakova M, Chovanec M, Ciernikova S, Danihel L. Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel. Bratislava Medical Journal. 2024. doi:10.4149/bll_2024_115
BibTeX
@article{Novisedlakova2024,
author = {Novisedlakova, Maria and Chovanec, Michal and Ciernikova, Sona and Danihel, Ludovit},
title = {Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel},
journal = {Bratislava Medical Journal},
year = {2024},
doi = {10.4149/bll_2024_115}
}
EUVIMED